Apidra Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Side Effects Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Insulin glulisine

Indications/Uses

Treatment of adults, adolescents & childn ≥6 yr w/ DM, where treatment w/ insulin is required.

Click to view Apidra detailed prescribing information

Dosage/Direction for Use

Individualized dosing by SC inj, continuous SC insulin infusion in pump systems suitable for insulin infusion or IV inj.

Click to view Apidra detailed prescribing information

Overdosage

View Apidra overdosage for action to be taken in the event of an overdose.

Administration

Should be taken with food: Administer w/in 15 min before or immediately after a meal.

Contraindications

Hypersensitivity & hypoglycemia.

Click to view Apidra detailed prescribing information

Special Precautions

Renal or hepatic impairment. Transfer from other types of insulin. Inadequate dosing or discontinuation of treatment. Monitor blood sugar level frequently. Contains metacresol which may cause allergic reactions. Do not mix w/ any prep other than NPH human insulin. Malfunction of the insulin pump or infusion set or handling errors can rapidly lead to hyperglycemia & diabetic ketoacidosis. May impair ability to drive or operate machinery. Pregnancy & lactation. Childn <6 yr.

Click to view Apidra detailed prescribing information

Use In Pregnancy & Lactation

Click to view Apidra detailed prescribing information

Adverse Reactions

Hypoglycemia; hyperglycemia; inj site reactions eg, reddening, unusually intense pain, itching, hives, swelling or inflammation; lipodystrophy.

Drug Interactions

Other antidiabetics, ACE inhibitors, disopyramide, fluoxetine, fibrates, MAOIs, pentoxifylline, propoxyphene, salicylates eg, aspirin, sulfonamides; corticosteroids, danazol, diazoxide, diuretics, glucagon, INH, estrogens, progestogens, phenothiazine derivatives, somatropin; sympathomimetics eg, epinephrine, salbutamol, terbutaline; thyroid hormones, PIs, atypical antipsychotics eg, olanzapine & clozapine; β-blockers, clonidine, guanethidine, reserpine, lithium salts, pentamidine, alcohol.

Click to view Apidra detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Apidra detailed prescribing information

Storage

View Apidra storage conditions for details to ensure optimal shelf-life.

Description

View Apidra description for details of the chemical structure and excipients (inactive components).

Action

View Apidra mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Insulin Preparations

ATC Classification

A10AB06 - insulin glulisine ; Belongs to the class of fast-acting insulins and analogues. Used in the treatment of diabetes.

Regulatory Classification

Presentation/Packing

Form

Apidra soln for inj 3.49 mg/mL (100 u/mL)

Packing/Price

10 mL x 1's (P1,240/pack)

Apidra

insulin glulisine

Manufacturer:

sanofi-aventis

Distributor:

sanofi-aventis